MedPath

景时(杭州)药业有限公司

Ownership
-
Established
2021-05-18
Employees
-
Market Cap
-
Website
www.jingshipharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Lidocaine and Prilocaine Cream

Product Name
利丙双卡因乳膏
Approval Number
国药准字H20253898
Approval Date
Apr 15, 2025
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20243498
Approval Date
Apr 17, 2024
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20243499
Approval Date
Apr 17, 2024
NMPA

Sildenafil Citrate Orodispersible Tablet

Product Name
枸橼酸西地那非口崩片
Approval Number
国药准字H20234251
Approval Date
Sep 28, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.